Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-026760

Chief Financial Officer acquired 1,108 shares (grant or award)

  • Chief Financial Officer gave up 517 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2024-03-01 Shares withheld for taxes −517 $24.06 $12,439 8,428 D
Mokari Atabak Chief Financial Officer 2024-03-01 Grant or award +554 $24.06 $13,329 8,982 D
Mokari Atabak Chief Financial Officer 2024-03-01 Grant or award +554 9,536 D
Loading xslF345X05/ownership.xml…